MyAverix Finance
NS · Pharmaceuticals
Hikal Ltd (HIKAL)
Pharmaceuticals & Biotechnology
Hikal Ltd (HIKAL) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $27.08B, P/E ratio is -55.60, net margin is 2.0%, dividend yield is 0.09%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HIKAL
Hikal Ltd (HIKAL) — FAQ
What is Hikal Ltd's market cap?
Hikal Ltd (HIKAL) has a reported market cap of $27.08B (data as of 2026-07-10).
What is HIKAL's P/E ratio?
The price-to-earnings (P/E) ratio for Hikal Ltd (HIKAL) is -55.60 (data as of 2026-07-10).
Does Hikal Ltd pay a dividend?
Hikal Ltd (HIKAL) shows a reported dividend yield of 0.09%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Hikal Ltd in?
Hikal Ltd (HIKAL) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is HIKAL listed on?
HIKAL is listed on NS.
What is Hikal Ltd's net margin?
Hikal Ltd (HIKAL) reports a net margin of 2.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.